Novo Nordisk A/S is selling bonds for the first time in more than two years to fund plans to ramp up production of its blockbuster drugs.
Ozempic Maker Novo Starts Bond Sale to Fund Factory PurchaseGerman Investor Confidence Jumps as Economic Recovery Takes HoldAsian Stocks Set for Cautious Open as CPI Looms: Markets WrapTurkey Underwhelms With New Spending Cuts to Curb InflationFraud Concerns Raise Red Flags for India’s Booming Tiny IPOsFlood of Chinese Used Cooking Oil Spurs Call to Boost US TariffsBiggest Saudi IPO of the Year Draws $91 Billion in OrdersUK Unemployment Rate Rises to Highest Since Last SummerBofA Strategist...
can diverge: MacklemTurkey Underwhelms With New Spending Cuts to Curb InflationBiden Imposes Tariffs on Chinese Chips, Critical Minerals, EVsSouth Africa Unemployment Rises, Pressuring ANC Before ElectionsRand Erases Losses on Optimism Over South African Vote OutcomeHong Kong Condemns UK’s Spying Allegations Against Trade OfficerAnglo Commitment to South Africa Welcomed by Unions, Cosatu SaysBiden Signs Ban on Imports of Russian Nuclear Reactor FuelModi Files Papers to Contest Election From...
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Ozempic Maker Novo Nordisk Plans Bond Sale to Fund ExpansionNovo Nordisk A/S plans to sell bonds for the first time in more than two years to help finance its large program to expand production of its blockbuster treatments.
Read more »
CEO of Oreo Maker Mondelez Sees Very Limited Impact From OzempicEven with appetite-suppressing drugs, people will keep eating Oreo cookies, according to the company that makes them.
Read more »
US Senate committee investigates pricing of Novo's Ozempic and WegovyExplore stories from Atlantic Canada.
Read more »
US Senate committee investigates pricing of Novo's Ozempic and WegovyExplore stories from Atlantic Canada.
Read more »
U.S. Senate committee investigates pricing of Novo’s Ozempic and WegovySenator Bernie Sanders sent a letter to Novo’s CEO seeking more information on U.S. prices for the two drugs, which are higher than the prices in other countries
Read more »
Ozempic Subsidies Cut in Novo Nordisk’s Home Country of DenmarkSubsidies for Ozempic will be restricted in Novo Nordisk A/S’s home country of Denmark due to rising public spending on the blockbuster diabetes medicine, which is increasingly being used as a weight-loss treatment.
Read more »